One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2014.32.15_suppl.tps4600
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
Affiliation: National and Kapodistrian University of Athens, Fondazione IRCCS Istituto Nazionale dei Tumori, GlaxoSmithKline (United States), University of Manchester, GlaxoSmithKline (United Kingdom), University Hospital Münster, Medical University of Vienna, Royal Shrewsbury Hospital, Comprehensive Cancer Centers of Nevada, Helsinki University Hospital, The University of Texas MD Anderson Cancer Center, Hospital de León, Hospital Universitario Lucus Augusti, Antwerp University HospitalTPS4600^ Background: Pazopanib is an oral, selective, multikinase inhibitor of VEGF receptors 1/2/3, PDGF receptors α/s, and stem cell factor receptor (c-Kit) that is approved for first-line treatm...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
